A prospective, single center study analysing efficacy of Vedolizumab in refractory microscopic colitis
Latest Information Update: 29 Jul 2022
At a glance
- Drugs Vedolizumab (Primary)
- Indications Colitis
- Focus Therapeutic Use
Most Recent Events
- 21 Dec 2020 New trial record
- 28 Oct 2020 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020